Lamas Cristina, Araujo-Castro Marta, Ostermair Lukas, Petersenn Erik, Parra Ramírez Paola, Rebollo-Román Ángel, Stuefchen Isabel, Bruedgam Denise, Ruiz-Sanchez Jorge Gabriel, Michalopoulou Theodora, Perdomo Carolina M, Hanzu Felicia A, Adolf Christian, Reincke Martin
Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de Albacete, 02001 Albacete, Spain.
Endocrinology Department, Hospital Ramón y Cajal, 28034 Madrid, Spain.
Biomedicines. 2024 Oct 23;12(11):2430. doi: 10.3390/biomedicines12112430.
: Mild autonomous cortisol secretion (MACS) can coexist with primary aldosteronism (PA). The purpose of our study was to evaluate whether (MACS) influences parameters analyzed during adrenal venous sampling (AVS) in patients with PA. : Patients with PA from the SPAIN-ALDO Registry and the German Conn's Registry with available 1 mg-dexamethasone suppression test (DST) and AVS were included. MACS was defined as a post-DST cortisol > 1.8 µg/dL in the absence of specific signs and symptoms of Cushing's syndrome. : Two-hundred and twenty-five patients were included, 98 (43.6%) of whom had concomitant MACS. The mean age was 54 ± 10 years and 37.3% were women. AVS was performed by simultaneous catheterization of both adrenal veins and analysis of basal samples in 157 patients (69.8%), with both basal and post-ACTH samples in 15 patients (6.7%), and during continuous ACTH infusion in 53 patients (23.6%). AVS was considered technically unsuccessful in 40 cases (17.8%), suggesting unilateral secretion in 106 (47.1%) and bilateral secretion in 79 (35.1%). We did not find significant differences in the percentage of unilateral and bilateral results, cortisol, corrected aldosterone, or selectivity indices in the dominant and non-dominant veins, nor in the lateralization index or the contralateral suppression index between patients with and without MACS. They also had similar rates of surgical treatment and biochemical and clinical response. : Although pathophysiological reasoning suggests that MACS could hinder AVS identification of unilateral forms of PA, our data suggest that such interference, if it exists, is of moderate clinical relevance.
轻度自主性皮质醇分泌(MACS)可与原发性醛固酮增多症(PA)共存。我们研究的目的是评估MACS是否会影响PA患者肾上腺静脉采样(AVS)期间分析的参数。:纳入来自西班牙醛固酮增多症注册研究和德国Conn综合征注册研究且有可用的1毫克地塞米松抑制试验(DST)和AVS的PA患者。MACS被定义为在没有库欣综合征的特定体征和症状的情况下,DST后皮质醇>1.8μg/dL。:共纳入225例患者,其中98例(43.6%)伴有MACS。平均年龄为54±10岁,女性占37.3%。157例患者(69.8%)通过同时插管双侧肾上腺静脉并分析基础样本进行AVS,15例患者(6.7%)同时分析基础样本和促肾上腺皮质激素(ACTH)后样本,53例患者(23.6%)在持续ACTH输注期间进行AVS。40例(17.8%)AVS在技术上未成功,提示单侧分泌106例(47.1%),双侧分泌79例(35.1%)。我们未发现伴有和不伴有MACS的患者在单侧和双侧结果的百分比、皮质醇、校正醛固酮或优势侧和非优势侧静脉的选择性指数方面存在显著差异,在侧别指数或对侧抑制指数方面也无显著差异。他们的手术治疗率以及生化和临床反应率也相似。:尽管病理生理学推理表明MACS可能会妨碍AVS对单侧PA形式的识别,但我们的数据表明,这种干扰(如果存在)具有中等临床相关性。